← Leaderboards
Candace S Brown
University Of Tennessee Health Sci Ctr
$825,878
Attributed
$2,474,455
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $667.6K · FY2011–14$1M$750K$500K$250K$0
'11
'12
'13
'14
Funding mix
By agency
NIH$2,474,455 · 2
By mechanism
R01$2,472,866 · 1
M01$1,589 · 1
Top collaborators
- Gloria A Bachmann4 shared
- David Charles Foster4 shared
Most similar at University Of Tennessee Health Sci Ctr
Same institution · by research overlap
- James M O'Donnell$6,936,708
Others in their field
Top investigators on “Diagnosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$590,717,255
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$337,858,596
- Richard K. Wilson · Washington University$297,645,172
- Sharon A Nachman · Johns Hopkins University$212,395,175
- Carol Nesel · Westat$188,148,170
Research focus
DiagnosisAge-YearsAdverse EffectsAffectAnxietyAreaBaseAnalgesicsAnti-Anxiety AgentsCalcium ChannelCapsaicinCardiacCentral SensitizationCharacteristicsChronic Neuropathic PainChronic PainClinical ApplicationBiologicalCoitusControl TrialCost EffectiveCross-Over StudiesData ManagementDiaries
Grant awards (5)
A Controlled Trial of Gabapentin in Vulvodynia: Biological Correlates of Response$535,667
R01 · FY2014 · HD · contact PI
A Controlled Trial of Gabapentin in Vulvodynia: Biological Correlates of Response$621,930
R01 · FY2013 · HD · contact PI
A Controlled Trial of Gabapentin in Vulvodynia: Biological Correlates of Response$647,691
R01 · FY2012 · HD · contact PI
A Controlled Trial of Gabapentin in Vulvodynia: Biological Correlates of Response$667,578
R01 · FY2011 · HD · contact PI
Trial of BOTX A in Treatment of Vulvar Vestibulitis Syndrome$1,589
M01 · FY2004 · RR